Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Scientists use computer simulations to identify future targets for treatment of Covid-19

University of Warwick scientists model movements of nearly 300 protein structures in Covid-19. Scientists can use the simulations to identify potential targets to test with existing drugs, and even check effectiveness with future Covid variants.

19 Feb 2021

Domestic dogs unlikely to transmit SARS-CoV-2, say researchers

Researchers in Spain and Germany have conducted a study showing that domestic dogs are unlikely to contribute to the transmission and community spread of SARS-CoV-2 – the agent that causes COVID-19.

19 Feb 2021

Researchers find CXCR6 gene plays a role in COVID-19 severity

Researchers in the United States have conducted a study demonstrating that a gene called CXCR6 (C-X-C Motif Chemokine Receptor 6) may play an important role in determining the severity of COVID-19.

19 Feb 2021

Does climate play a large role in SARS-CoV-2 transmission?

A team of researchers from the Universidade Federal de Itajuba in Brazil has reported that weather plays a vital role in determining the transmission rate of SARS-CoV-2 infection.

19 Feb 2021

Climate change may have contributed to the COVID-19 pandemic

In this interview, News-Medical speaks to Dr. Robert Beyer about his latest research that discovered that climate change may have contributed to the COVID-19 pandemic.

19 Feb 2021

How does the SARS-CoV-2 E484K mutation increase viral fitness?

How do mutations benefit SARS-CoV-2? To explore this, a team of researchers from China took a closer look at the physical interactions that occur between the proteins after viral mutation.

19 Feb 2021

Study: First influenza infection does not make people immune to future flu viruses

A child's first influenza infection shapes their immunity to future airborne flu viruses - including emerging pandemic strains.

19 Feb 2021

Cologne University professor heads new consortium on EU vaccine research network

The European Union is funding the establishment of the new vaccine research network VACCELERATE with a total of 12 million euros for three years.

18 Feb 2021

Inhibitors to target SARS-CoV-2 viral protein display strong antiviral activity in transgenic mouse model

Inhibitors based on approved drugs and designed to disrupt the SARS-CoV-2 viral protein Mpro display strong antiviral activity both in vitro and in a transgenic mouse model, a new study reports.

18 Feb 2021

Immune response to SARS-CoV-2 may be limited by a set of genes

Neutralizing antibodies develop within two weeks of a SARS-CoV-2 infection, but their durability and intensity can vary by individual, prompting concerns about the prospects of long-lasting immunity and efficacy of COVID-19 vaccines.

18 Feb 2021

Zambia study casts doubt on the assumption that COVID-19 skipped Africa

A new study concluding out of Lusaka, Zambia last summer has found that as many as 19% (almost 1 in 5) of recently-deceased people tested positive for COVID-19.

18 Feb 2021

USDA, FDA highlight no credible evidence of COVID-19 transmission through food or food packaging

After more than a year since the coronavirus disease 2019 (COVID-19) outbreak was declared a global health emergency, the U.S. Department of Agriculture, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention continue to underscore that there is no credible evidence of food or food packaging associated with or as a likely source of viral transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19.

18 Feb 2021

Changes in drinking and smoking during England’s first COVID-19 lockdown

The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 infection in early 2020 prompted many nations to close their borders and institute mandatory lockdowns. While lockdowns abruptly stopped daily life, researchers from the University College London and the University of Sheffield found drug-seeking behaviors did not.

18 Feb 2021

O-glycosylation of SARS-CoV-2 spike protein in insect and human cell lines

The mapping of O-glycosites requires instruments that can support electron transfer dissociation (ETD) fragmentation. In a new study published on the bioRxiv preprint server, researchers report their results on whether O-glycosylation patterns affect immunogens for vaccine development.

18 Feb 2021

Study: COVID-19 rates fall faster in richer countries

Richer countries were more likely to see rates of COVID-19 fall faster during the first wave of the pandemic, according to new research published in the journal Frontiers in Public Health.

18 Feb 2021

Could measles virus vectors be used for a new COVID-19 vaccine?

A research team at the Institut Pasteur in France describes the successful development of such a vaccine utilizing a measles virus vector.

18 Feb 2021

Restricting testing to 'classic triad' of symptoms may have missed some COVID-19 cases

Extending the symptoms that trigger a PCR test for COVID-19 could help detect around a third more cases of the disease.

18 Feb 2021

Study reveals extremely low detection of SARS-CoV-2 on surfaces in oncology facilities

Researchers from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility.

18 Feb 2021

KHN’s ‘What the Health?’: Open enrollment, one more time

An estimated 9 million Americans eligible for free or reduced premium health insurance under the Affordable Care Act have a second chance to sign up for 2021 coverage, since the Biden administration reopened enrollment on healthcare.gov and states that run their own marketplaces followed suit.

18 Feb 2021

Clinical trial launched to analyze bovine-derived immunoglobulins for preventing COVID-19 side effects

The Hospital del Mar Medical Research Institute (IMIM), Hospital del Mar, the University of California-Davis and the University of Texas have launched a clinical trial to analyze how useful a food supplement can be for preventing the worst side effects of COVID-19.

18 Feb 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Scientists use computer simulations to identify future targets for treatment of Covid-19

Domestic dogs unlikely to transmit SARS-CoV-2, say researchers

Researchers find CXCR6 gene plays a role in COVID-19 severity

Does climate play a large role in SARS-CoV-2 transmission?

Climate change may have contributed to the COVID-19 pandemic

How does the SARS-CoV-2 E484K mutation increase viral fitness?

Study: First influenza infection does not make people immune to future flu viruses

Cologne University professor heads new consortium on EU vaccine research network

Inhibitors to target SARS-CoV-2 viral protein display strong antiviral activity in transgenic mouse model

Immune response to SARS-CoV-2 may be limited by a set of genes

Zambia study casts doubt on the assumption that COVID-19 skipped Africa

USDA, FDA highlight no credible evidence of COVID-19 transmission through food or food packaging

Changes in drinking and smoking during England’s first COVID-19 lockdown

O-glycosylation of SARS-CoV-2 spike protein in insect and human cell lines

Study: COVID-19 rates fall faster in richer countries

Could measles virus vectors be used for a new COVID-19 vaccine?

Restricting testing to 'classic triad' of symptoms may have missed some COVID-19 cases

Study reveals extremely low detection of SARS-CoV-2 on surfaces in oncology facilities

KHN’s ‘What the Health?’: Open enrollment, one more time

Clinical trial launched to analyze bovine-derived immunoglobulins for preventing COVID-19 side effects

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in